EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • January 17th, 2012 • Vermillion, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJanuary 17th, 2012 Company IndustryTHIS EXCLUSIVE DISTRIBUTION AGREEMENT (the “Agreement”) is made and entered into the 1st day of August, 2011 (“Effective Date”), by and between Vermillion Inc., a Delaware corporation with its principal business address at 12117 Bee Caves Rd. Building III, Suite 100, Austin, TX 78738, USA (“Supplier”) and Pronto Diagnostics Ltd., an Israeli company with registered address at 19a Habarzel St., Ramat Hachayal, Tel Aviv 69710, Israel (“Distributor”).
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • August 9th, 2011 • Vermillion, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledAugust 9th, 2011 Company IndustryTHIS EXCLUSIVE DISTRIBUTION AGREEMENT (the “Agreement”) is made and entered into the 1st day of August, 2011 (“Effective Date”), by and between Vermillion Inc., a Delaware corporation with its principal business address at 12117 Bee Caves Rd. Building III, Suite 100, Austin, TX 78738, USA (“Supplier”) and Pronto Diagnostics Ltd., an Israeli company with registered address at 19a Habarzel St., Ramat Hachayal, Tel Aviv 69710, Israel (“Distributor”).